Changes to Biohit Oyj’s management
Biohit Oyj
Stock exchance release
16 December 2011
11:50 A.M.
Semi Korpela, M.Sc. (Econ.), born 1970, was appointed President and CEO of Biohit Group as of 15 December 2011. Previously, Korpela worked as the Financial Director of Biohit Group from 2003 to 2006. After this, Korpela held positions as Financial Director at CPS Color Group, Medisize Group and LDR Group Oy.
Tapani Tiusanen, PhD. (Physics), DipEMC (Marketing), born 1956, was appointed the new Head of Operations and IT of Biohit Group as of 16 December 2011. Previously, Tiusanen worked in several positions at Labsystems Oyj, Vaisala Oyj and Kibron Inc. and for the last three years as Development Manager at Biohit Group.
Ulla Savelainen, B.Sc. Econ., born 1949, was appointed Head of Financials, HR and Communications of Biohit Group as of 16 December 2011. Previously, Savelainen worked as a Financial Administration Consultant in several listed companies. From 2000 to 2005, Savelainen worked as the Financial Manager of Sentera Oyj.
Terhi Lampén, M.Sc. (Econ.), born 1973, was appointed Head of Sales and Marketing of Biohit Group as of 16 December 2011. Previously, Lampén worked as the Nordic Sales Manager of the Diagnostics business and from the beginning of 2011 onwards as the Marketing Manager. Before her career at Biohit, Lampén worked as a Product Specialist at Johnson & Johnson and as a Regional Manager at Boehringer Ingelheim.
Lea Paloheimo, PhD (Clinical Biochemistry), was appointed Head of Product Development and Quality of Biohit Group as of 16 December 2011. Paloheimo has worked at Biohit Group since 2001. Before her career at Biohit Group, Paloheimo has worked as a Chemist at Huslab, a Sales Manager Dasico a/s in Denmark, a Researcher at Orion Diagnostica (Orion Corporation) and a Chemist at the Clinical Chemistry department of United Laboratories Ltd. She carried out her PhD and postdoctoral research at the University of Copenhagen.
For further details, contact:
Osmo Suovaniemi
MD, PhD, Professor
Chairman of the Board of Directors
Tel. +358 40 745 5605
osmo.suovaniemi@biohit.fi
Distribution:
NASDAQ
OMX Helsinki Oyj
Central Storage Facility (www.oam.fi)
Press
www.biohit.fi
About Biohit
Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit's mission crystallises in its motto “Innovating for Health”. The company assumes social responsibility by producing innovations, new technologies and analysis systems for use in medicine, research institutions and industry. These products help to promote research and diagnostics, while improving quality of life by preventing disease, human suffering and financial loss. Biohit also seeks to innovate and develop the marketing and availability of its products and services, in order to ensure its profitable growth and ability to pay dividends.
Biohit works with scientific communities to produce new technologies, products and services based on research results and innovations. These can be used to develop safe and cost-effective diagnostic tests for the early detection and prevention of diseases of the gastrointestinal tract. (www.biohit.fi / International / State of the art GastroPanel and Acetium innovations for the unmet need)
Biohit's products include analysis systems for the prevention and early diagnosis of gastrointestinal diseases, such as the blood-sample based GastroPanel examinations for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and H. pylori infection in connection with gastroscopy, and the ColonView examination for the early detection of intestinal bleeding that indicates a risk of colorectal cancer. Acetium reduces the amount of carcinogenic acetaldehyde in an anacidic stomach. (www.acetium.com/test - reveals acetaldehyde exposure)
Biohit employs around 35 people. The company is headquartered in Helsinki, Finland and has a subsidiary in the UK. Since 1999, Biohit’s Series B share (BIOBV) has been quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group and is traded under the code BIOBV (www.biohit.fi).
Read more at www.biohit.fi